Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Korea To Cut Drug Prices By Up To 20% For Inferior Efficacy Results; More Cuts Expected

This article was originally published in PharmAsia News

Executive Summary

SEOUL - South Korea's Ministry of Health and Welfare will cut prices of 664 drugs by up to 20% after conducting a peer drug review of 2,398 products. The cuts will begin in July and will roll out over the next three years
Advertisement

Related Content

Korea Moves To Cut Drug Prices Of Seven Pharma Companies Over Rebates
Korea To Charge Patients More For Drugs Dispensed At Largest Hospitals
Korea To Charge Patients More For Drugs Dispensed At Largest Hospitals
Advertisement
UsernamePublicRestriction

Register

SC078163

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel